WATCH: Netcare CEO Richard Friedland on the group’s robust annual results

Business Day TV talks to Life Healthcare CEO Peter Wharton-Hood

Lilly says the injection device in question will be different from the pen Lilly plans to use for the weight-loss drug in the US

Strong sales of cancer treatments offsets loss of Covid-19 vaccine sales

Shares rise on report Elliott has spent more than $1bn on a stake in the pharma company

Orthopaedics is its largest product segment and could benefit from powerful weight-loss drugs as more overweight people become more eligible for a knee ...

SPONSORED | The health insurance product provider addresses Africa’s cancer crisis with progressive, comprehensive gap cover solutions

Drugmaker looks beyond vaccine as it reports quarterly loss on Paxlovid charge

But CEO Paul Hudson says the core innovative drugs business has improved enough to soon do without the more predictable cash flows from consumer products

Drugmaker to pay Daiichi Sankyo $4bn up front and $1.5bn in payments over the next two years

Business Day TV talks to Rich Sacini, president  of  health trade union Haitu

Business Day TV talks to Primary Health Property CEO  Harry Hyman